Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$2.88 - $4.89 $743 - $1,261
-258 Reduced 0.85%
30,002 $103,000
Q4 2023

Feb 13, 2024

SELL
$1.08 - $3.63 $131 - $442
-122 Reduced 0.4%
30,260 $98,000
Q3 2023

Nov 13, 2023

BUY
$2.81 - $5.69 $3,034 - $6,145
1,080 Added 3.69%
30,382 $88,000
Q2 2023

Aug 04, 2023

BUY
$4.45 - $7.57 $130,393 - $221,816
29,302 New
29,302 $159,000
Q2 2022

Aug 12, 2022

SELL
$1.92 - $6.28 $57,479 - $188,004
-29,937 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$5.07 - $7.2 $10,682 - $15,170
-2,107 Reduced 6.58%
29,937 $180,000
Q4 2021

Feb 11, 2022

SELL
$5.67 - $8.54 $5,437 - $8,189
-959 Reduced 2.91%
32,044 $206,000
Q3 2021

Nov 12, 2021

SELL
$13.4 - $16.3 $10,505 - $12,779
-784 Reduced 2.32%
33,003 $455,000
Q2 2021

Aug 13, 2021

SELL
$14.81 - $19.13 $9,744 - $12,587
-658 Reduced 1.91%
33,787 $501,000
Q1 2021

May 07, 2021

BUY
$14.52 - $23.53 $1,321 - $2,141
91 Added 0.26%
34,445 $613,000
Q4 2020

Feb 12, 2021

SELL
$10.14 - $15.19 $9,987 - $14,962
-985 Reduced 2.79%
34,354 $491,000
Q3 2020

Nov 04, 2020

BUY
$9.57 - $21.32 $31,198 - $69,503
3,260 Added 10.16%
35,339 $357,000
Q2 2020

Aug 12, 2020

BUY
$12.21 - $16.99 $21,904 - $30,480
1,794 Added 5.92%
32,079 $472,000
Q1 2020

May 04, 2020

BUY
$9.03 - $19.72 $6,564 - $14,336
727 Added 2.46%
30,285 $405,000
Q4 2019

Feb 05, 2020

BUY
$13.01 - $17.15 $2,133 - $2,812
164 Added 0.56%
29,558 $416,000
Q3 2019

Nov 08, 2019

SELL
$14.55 - $20.56 $2,968 - $4,194
-204 Reduced 0.69%
29,394 $480,000
Q2 2019

Aug 13, 2019

SELL
$15.0 - $19.62 $855 - $1,118
-57 Reduced 0.19%
29,598 $464,000
Q1 2019

May 06, 2019

SELL
$11.65 - $17.72 $5,976 - $9,090
-513 Reduced 1.7%
29,655 $515,000
Q4 2018

Feb 13, 2019

SELL
$10.72 - $16.73 $2,497 - $3,898
-233 Reduced 0.77%
30,168 $336,000
Q3 2018

Nov 09, 2018

BUY
$17.73 - $26.69 $9,733 - $14,652
549 Added 1.84%
30,401 $742,000
Q2 2018

Aug 08, 2018

BUY
$10.79 - $24.44 $8,340 - $18,892
773 Added 2.66%
29,852 $542,000
Q1 2018

May 07, 2018

SELL
$9.0 - $20.16 $14,085 - $31,550
-1,565 Reduced 5.11%
29,079 $325,000
Q4 2017

Feb 09, 2018

BUY
$13.26 - $22.86 $36,160 - $62,339
2,727 Added 9.77%
30,644 $595,000
Q3 2017

Nov 09, 2017

BUY
$19.76 - $24.9 $551,639 - $695,133
27,917
27,917 $604,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.